quetiapine-fumarate and Mitral-Valve-Insufficiency

Electroconvulsive therapy (ECT) is especially necessary to revert some types of depressive disease; nevertheless, it has some widely recognized adverse effects, such as short-term memory loss. Moreover, some articles have reported its potential association with falls; this literature is, however, scanty and mainly consists of case reports. We present the case of a man who has a diagnosis of neurally mediated syncope at the age of 79 years, during the maintenance ECT. The patient had a significant increase in syncope frequency in the period he was treated with ECT, followed by a dramatic decrease when ECT was discontinued.

Topics: Aged; Antipsychotic Agents; Baroreflex; Depressive Disorder, Major; Dibenzothiazepines; Electroconvulsive Therapy; Humans; Male; Mitral Valve Insufficiency; Quetiapine Fumarate; Syncope; Unconsciousness; Urination